Documents / Official release
This Defense Intelligence Reference Document, dated 7 January 2010, was prepared by the Defense Intelligence Agency's Defense Warning Office. It is one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications program. The report reviews biomaterials used in medicine, including silicones, Teflon, biodegradable polymers, hydrogels, titanium, ceramics and tissue constructs, and applications such as stents, joints, contact lenses, drug delivery and dialysis. It concludes that most innovation lies in new ways to apply existing materials.
From the source: Release of 2026-09-18 Incident: 1/7/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD is a broad survey of biomaterials, including metals, polymers, ceramics, glasses, and composites designed to interact with living tissue, and argues that their value depends mainly on biocompatibility, reliability, and careful matching of material properties to specific medical uses. The report reviews major application areas including biosensors, implants, cardiovascular devices, contact lenses, drug delivery systems, tissue constructs, titanium devices, and dialysis membranes, emphasizing that no single biomaterial works best in every setting. Its overall conclusion is that biomaterials are already foundational to a large medical-device industry and save or improve millions of lives, but that progress tends to be slow because safety testing is stringent; as a result, most advances come from improved ways of applying established materials such as silicone, Teflon, biodegradable polymers, ceramics, and titanium in new devices and clinical settings rather than from radically new substances.
UNCLASSIFIED/ ;'FOR OFFI@IAL YSE OHL¥ SILICONE CHEMISTRY Silicone is actually a common name for the chemical compound polydimethylsiloxane (PDMS), a class of synthetic polymers with repeating units of silicon and oxygen. Figure 5 shows the polymeric repeating structure of medical silicones. Various functional groups-often methyl-can be attached to that backbone to change the material properties. Silicone polymers can easily be transformed into linear or cross linking materials without using any toxic plasticizers . The resulting materials are elastic at body temperature. The simultaneous presence of Figures. Silicone Chemical Groups different groups attached to the silicon-oxygen backbone gives silicones a range of viscous and mechanical properties that allow their use as fluids, emulsions, compounds, resins, and elastomers in numerous applications. Thus, silicone is a versatile polymer, although its use is often limited by its relatively poor mechanical strength. However, this limitation can be overcome by reinforcing silicone with a silica filler or by chemically modifying the backbone. The stability, lack of toxicity, and excellent biocompatibility of PDMS make these materials well suited for use in personal care, pharmaceutical, and medical device applications. Silicone is easily molded and cast using room temperat ure curing (known as RTV) or through the use of an organic catalyst. SILICONE IN BIOMEDICAL PRODUCTS Silicone membranes are made by casting the silicone liquid precursor into thin sheets. Such membranes are often used in oxygen and carbon dioxide blood biosensors because membranes made of this material are highly transmissive to these gases while they block most other chemical substances present in the blood stream. In addition, silicone's resistance to protein adhesion and its excellent overall biocompatibility make it one of the most commonly used materials for encapsulating biosensors for tissue or blood contact. Recent formu lations of silicone can be patterned with ultraviolet light and, thus, lend themselves to manufacture with biosensors made by photolithography. UNCLASSIFIED/ /EOR OFFICilAk YSE 8HLY 4
Not linked to a story yet.
Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 32 pages are in the text index: search them above, or from the library's search.